BIG PHARMA EARNINGS WATCH: ABBVIE, ASTRAZENECA, AMGEN

Big Pharma Drugmakers Top Wall Street Estimates After Hiking Drug Prices Earlier This Year This week, brand name drug giants AbbVie, AstraZeneca and Amgen all announced earnings and profits for the

08-5-2022 Read More

SECOND OPINION: PHRMA’S LAST-DITCH ATTEMPT TO DERAIL SOLUTIONS TO LOWER DRUG PRICES REHASHES DEBUNKED ARGUMENTS

Pharmaceutical Industry Attempts to Intimidate Lawmakers and Keep Prices High by Re-Upping False Claims, Blame Game and Discredited Innovation Rhetoric On Thursday

08-5-2022 Read More

ICYMI: CIVICASCRIPT BRINGS FIRST GENERIC DRUG TO MARKET TO PROVIDE MORE AFFORDABLE ALTERNATIVE TO HIGH-PRICED BIG PHARMA PRODUCTS

Private Sector and Non-Profit Partners Introduce Cancer Treatment That Can Save Patients Thousands of Dollars Per Month In case you missed it, CivicaScript

08-3-2022 Read More

BIG PHARMA EARNINGS WATCH: PFIZER, MERCK, BRISTOL MYERS SQUIBB, GLAXOSMITHKLINE AND SANOFI

Big Pharma Giants All Top Analysts’ Expectations as Pharmaceutical Industry Continues to Price-Gouge and Fight Market-Based Solutions to Lower Drug Prices In another round of blockbuster earnings

07-29-2022 Read More

CSRXP COMMENDS ADVANCEMENT OF BILL TO BOOST AGENCY COOPERATION TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE

Bipartisan Interagency Patent Coordination and Improvement Act of 2022 Will Help Hold Brand Name Drug Companies Accountable, Support Pharmaceutical Competition For Immediate Release Contact: Jon

07-28-2022 Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON, ROCHE, NOVARTIS

Big Pharma Kicks Off Q2 Earnings Calls After More than 100 Price Hikes to Start July This week, Roche, Novartis, and Johnson & Johnson kicked off the first round of Big Pharma earnings reports

07-22-2022 Read More

CSRXP: INSULIN ACT MAY PROVIDE SHORT TERM RELIEF FOR SOME PATIENTS BUT WON’T ADDRESS ROOT CAUSE OF OUT-OF-CONTROL DRUG PRICES

Congress Must Advance Bipartisan, Market-Based Solutions to Hold Big Pharma Accountable for Egregious Anti-Competitive and Pricing Practices to Lower Rx Prices For Immediate Release Contact: Jon

07-19-2022 Read More

ICYMI: USPTO, FDA ANNOUNCE PLAN TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE

Joint Effort Aims to Curb Anti-Competitive Tactics Used by Brand Name Drug Companies to Block More Affordable Alternatives In case you missed it, the U.S.

07-19-2022 Read More

CSRXP: BIG PHARMA BRAZENLY INCREASES PRICES ON MORE THAN 100 DRUGS TO START JULY PRICE-GOUGING

Brand Name Drug Companies Begin Second Round of Biannual Price Hikes While Pointing Fingers at Others to Evade Accountability For Immediate Release Contact: Jon Conradi 860-235-3884

07-12-2022 Read More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.